In addition, the silencing of the oncogenic H3K9me3 methyltransferase SETDB1, which reduces cell viability and survival, appears to significantly increase SLC17A7 mRNA levels in pediatric high-grade gliomas, further confirming its tumor suppressive role [80]. This evidence concerns the gene SLC17A7 and central nervous system cancer.